25 GLYSET (Glyset 25 mg)
Generic Name: miglitol
Pill imprint 25 GLYSET has been identified as Glyset 25 mg.
Glyset is used in the treatment of diabetes, type 2 and belongs to the drug class alpha-glucosidase inhibitors. There is no proven risk in humans during pregnancy. Glyset 25 mg is not a controlled substance under the Controlled Substance Act (CSA).
Glyset
- Generic Name:
- miglitol
- Imprint:
- 25 GLYSET
- Strength:
- 25 mg
- Color:
- White
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Alpha-glucosidase inhibitors
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Pfizer U.S. Pharmaceuticals Group
- National Drug Code (NDC):
- 00009-5012
- Inactive Ingredients:
- microcrystalline cellulose
magnesium stearate
hypromelloses
polyethylene glycol
titanium dioxide
polysorbate 80
corn starch
More about Glyset (miglitol)
Consumer resources
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
